Overview of Basic Immunology for Clinical Investigators

被引:0
作者
Stephen, Bettzy [1 ]
Hajjar, Joud [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
来源
IMMUNOTHERAPY | 2017年 / 995卷
关键词
Adaptive; CTLA-4; Immune checkpoints; Tumor immunotherapy; Innate; PD-1; T cells; REGULATORY T-CELLS; TUMOR-ASSOCIATED MACROPHAGES; MAST-CELLS; INNATE IMMUNITY; CANCER-IMMUNOTHERAPY; SIGNALING PATHWAYS; BREAST-CANCER; SUPPRESSOR-CELLS; HUMAN-ANTIBODIES; HUMAN BASOPHILS;
D O I
10.1007/978-3-319-53156-4_1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor exists as a complex network of structures with an ability to evolve and evade the host immune surveillance mechanism. The immune milieu which includes macrophages, dendritic cells, natural killer cells, neutrophils, mast cells, B cells, and T cells are found in the core, the invasive margin, or the adjacent stromal or lymphoid component of the tumor. The immune infiltrate is heterogeneous and varies within a patient and between patients of the same tumor histology. The location, density, functionality, and the cross talk between the immune cells in the tumor microenvironment influence the nature of immune response, prognosis, and treatment outcomes in cancer patients. Therefore, an understanding of the characteristics of the immune cells and their role in tumor immune surveillance is of paramount importance to identify immune targets and to develop novel immune therapeutics in the war against cancer. In this chapter, we provide an overview of the individual components of the human immune system and the translational relevance of predictive biomarkers.
引用
收藏
页码:1 / 31
页数:31
相关论文
共 192 条
  • [61] Early interleukin-4: Its role in the switch towards a Th2 response and IgE-mediated allergy
    Haas, H
    Falcone, FH
    Holland, MJ
    Schramm, G
    Haisch, K
    Gibbs, BF
    Bufe, A
    Schlaak, M
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 119 (02) : 86 - 94
  • [62] Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
    Hadrup, Sine
    Donia, Marco
    Straten, Per thor
    [J]. CANCER MICROENVIRONMENT, 2013, 6 (02) : 123 - 133
  • [63] Molecular Control of Steady-State Dendritic Cell Maturation and Immune Homeostasis
    Hammer, Gianna Elena
    Ma, Averil
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, VOL 31, 2013, 31 : 743 - 791
  • [64] Prognostic value of tumor-associated macrophage count in human bladder cancer
    Hanada, T
    Nakagawa, M
    Emoto, A
    Nomura, T
    Nasu, N
    Nomura, Y
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2000, 7 (07) : 263 - 269
  • [65] The hallmarks of cancer
    Hanahan, D
    Weinberg, RA
    [J]. CELL, 2000, 100 (01) : 57 - 70
  • [66] The immunogenicity of humanized and fully human antibodies Residual immunogenicity resides in the CDR regions
    Harding, Fiona A.
    Stickler, Marcia M.
    Razo, Jennifer
    DuBridge, Robert B.
    [J]. MABS, 2010, 2 (03) : 256 - 265
  • [67] RESOLUTION AND CHARACTERIZATION OF PRO-B AND PRE-PRO-B CELL STAGES IN NORMAL MOUSE BONE-MARROW
    HARDY, RR
    CARMACK, CE
    SHINTON, SA
    KEMP, JD
    HAYAKAWA, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) : 1213 - 1225
  • [68] Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
    Herbst, Roy S.
    Baas, Paul
    Kim, Dong-Wan
    Felip, Enriqueta
    Perez-Gracia, Jose L.
    Han, Ji-Youn
    Molina, Julian
    Kim, Joo-Hang
    Arvis, Catherine Dubos
    Ahn, Myung-Ju
    Majem, Margarita
    Fidler, Mary J.
    de Castro, Gilberto, Jr.
    Garrido, Marcelo
    Lubiniecki, Gregory M.
    Shentu, Yue
    Im, Ellie
    Dolled-Filhart, Marisa
    Garon, Edward B.
    [J]. LANCET, 2016, 387 (10027) : 1540 - 1550
  • [69] Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
    Herbst, Roy S.
    Soria, Jean-Charles
    Kowanetz, Marcin
    Fine, Gregg D.
    Hamid, Omid
    Gordon, Michael S.
    Sosman, Jeffery A.
    McDermott, David F.
    Powderly, John D.
    Gettinger, Scott N.
    Kohrt, Holbrook E. K.
    Horn, Leora
    Lawrence, Donald P.
    Rost, Sandra
    Leabman, Maya
    Xiao, Yuanyuan
    Mokatrin, Ahmad
    Koeppen, Hartmut
    Hegde, Priti S.
    Mellman, Ira
    Chen, Daniel S.
    Hodi, F. Stephen
    [J]. NATURE, 2014, 515 (7528) : 563 - +
  • [70] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) : 711 - 723